Integra LifeSciences Holdings Corporation
DE ˙ DB ˙ US4579852082
14,80 € ↑1,10 (8,03%)
2026-06-05
DEL PRIS
SecurityDE:IL3 / Integra LifeSciences Holdings Corporation
InstitutionSapience Investments, LLC
Latest Disclosed Ownership1,914 shares
Latest Disclosed Value $ 18,030
Sapience Investments, LLC reports 95.96% decrease in ownership of IL3 / Integra LifeSciences Holdings Corporation

On May 15, 2026 - Sapience Investments, LLC filed a 13F-HR form disclosing ownership of 1,914 shares of Integra LifeSciences Holdings Corporation (DE:IL3) valued at $15,121 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 47,382 shares of Integra LifeSciences Holdings Corporation. This represents a change in shares of -95.96% during the quarter. The current value of the position is $28,327 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,914 -45,468 -95.96 18 -96.94 2.3357
2026-02-17 2025-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 47,382 7,385 18.46 588 2.62 2.2206
2025-11-14 2025-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 39,997 -178,995 -81.74 573 -78.68 2.2451
2025-08-14 2025-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 218,992 76,170 53.33 2,687 -14.43 1.7949
2025-05-15 2025-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 142,822 -21,953 -13.32 3,141 -15.98 2.2442
2025-02-14 2024-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 164,775 24,830 17.74 3,737 47.01 2.1818
2024-11-14 2024-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 139,945 -260 -0.19 2,543 -37.77 1.2578
2024-08-14 2024-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 140,205 -15,592 -10.01 4,086 -26.04 2.0874
2024-05-15 2024-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 155,797 -75,340 -32.60 5,523 -45.13 1.8308
2024-02-14 2023-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 231,137 -14,563 -5.93 10,066 7.28 2.3961
2023-11-14 2023-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 245,700 21,481 9.58 9,383 1.75 2.2556
2023-08-14 2023-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 224,219 31,650 16.44 9,222 -16.58 2.0749
2023-05-15 2023-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 192,569 -11,280 -5.53 11,055 -3.27 2.5557
2023-02-14 2022-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 203,849 -53,250 -20.71 11,430 4.94 2.3995
2022-11-14 2022-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 257,099 92,010 55.73 10,891 22.10 2.2868
2022-08-15 2022-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 165,089 -32,351 -16.39 8,920 -29.69 1.6715
2022-05-16 2022-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 197,440 -7,950 -3.87 12,687 -7.79 1.5411
2022-02-14 2021-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 205,390 27,785 15.64 13,759 13.13 1.5671
2021-11-15 2021-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 177,605 15,945 9.86 12,162 10.24 1.4444
2021-08-16 2021-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 161,660 -7,665 -4.53 11,032 -5.70 1.3704
2021-05-17 2021-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 169,325 -79,310 -31.90 11,699 -27.52 1.4684
2021-02-16 2020-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 248,635 -18,280 -6.85 16,141 28.06 2.2445
2020-11-16 2020-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 266,915 54,210 25.49 12,604 26.10 2.2365
2020-08-14 2020-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 212,705 -60,355 -22.10 9,995 -18.06 1.8383
2020-05-15 2020-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 273,060 18,830 7.41 12,198 -17.68 2.7134
2020-02-14 2019-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 254,230 90,720 55.48 14,817 50.86 2.0716
2019-11-14 2019-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 163,510 -300 -0.18 9,822 7.36 1.3661
2019-08-14 2019-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 163,810 31,000 23.34 9,149 23.64 1.2461
2019-05-13 2019-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 132,810 132,810 7,400 0.9844
2017-05-12 2017-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -35,200 -100.00 0 -100.00
2017-02-14 2016-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 35,200 35,200 3,020 0.9283
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.